China NMPA Product Recall - Transend Guidewire

Boston Scientific Corporation has initiated a voluntary recall of its Transend Guidewire, as reported by Stryker (Beijing) Medical Devices Co., Ltd. The recall, publicly announced on December 30, 2021, addresses a significant compliance issue: specific models and batches of the guidewires were sterilized in a facility not approved in Japan. This raises concerns regarding adherence to international sterilization standards and potential implications for product safety and efficacy. The National Medical Products Administration (NMPA) in China, the regulatory body overseeing medical devices, published this information, indicating the recall falls under their purview. While initiated voluntarily by Boston Scientific, the action highlights the critical importance of ensuring that all manufacturing and sterilization processes strictly comply with regional and international regulatory requirements. The required action involves the immediate retrieval of the affected Transend Guidewire, identified by Registration Certificate No.: 20173770330. Detailed specifics regarding the models, specifications, and batch numbers impacted by this recall are provided in the accompanying "Medical Device Recall Event Report Form" attachment, emphasizing the company's commitment to patient safety and regulatory compliance.